Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA source : Www.globenewswire.com save search
Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Published: 2022-12-19 (Crawled : 07:00) - globenewswire.com
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 21.77%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.54%
H: 0.51%
C: -0.25%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.82%
H: 0.23%
C: -0.11%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 35.79%
H: 10.85%
C: 2.71%
pharma collaboration natural therapeutics sanofi
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
Published: 2021-09-23 (Crawled : 05:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.34%
H: 0.3%
C: -0.12%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.33%
H: 0.6%
C: 0.16%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 2.08%
H: 0.68%
C: -4.76%
pharma
Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
Published: 2021-09-17 (Crawled : 12:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 32.17%
H: 57.24%
C: 6.58%
trial presentation
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Published: 2021-09-15 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.32%
H: 0.05%
C: -0.08%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: -0.55%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 11.15%
H: 0.48%
C: -8.22%
financial results results pharma
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
Published: 2021-09-07 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.24%
H: 0.12%
C: -0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.02%
H: 0.08%
C: -0.21%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -15.12%
H: 12.45%
C: 11.69%
conference pharma
Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
Published: 2021-09-02 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.58%
H: 0.36%
C: 0.29%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.13%
H: 0.28%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 44.48%
H: 7.46%
C: -20.08%
Innate Pharma to Participate in Upcoming Investor Conferences
Published: 2021-08-30 (Crawled : 05:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.18%
H: 1.47%
C: 0.95%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: -0.28%
conference pharma
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
Published: 2021-08-11 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.11%
H: 0.88%
C: 0.51%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.26%
H: 0.14%
C: -0.69%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -3.01%
H: 1.12%
C: 1.12%
pharma
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021
Published: 2021-07-12 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.22%
H: 0.4%
C: -0.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.84%
H: 0.27%
C: -0.38%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.0%
H: 3.63%
C: 1.51%
pharma
Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
Published: 2021-07-06 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.54%
H: 0.03%
C: -0.23%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.0%
H: 0.1%
C: -0.25%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -3.41%
H: 2.32%
C: -0.59%
covid phase 2 trial covid-19
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
Published: 2021-06-16 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.2%
H: 0.49%
C: -0.91%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.15%
H: 0.3%
C: -0.78%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -1.0%
H: 0.76%
C: -0.88%
pharma
Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
Published: 2021-06-14 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.49%
H: 0.48%
C: 0.46%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.15%
H: 0.71%
C: 0.69%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: -1.68%
pharma
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
Published: 2021-06-10 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.31%
H: 1.42%
C: 1.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.21%
H: 1.07%
C: 0.67%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 2.87%
H: 5.33%
C: 4.82%
pharma
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
Published: 2021-06-09 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.01%
H: 0.57%
C: 0.46%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.52%
H: 2.47%
C: -0.26%
presentation trial conference
Outcome of Innate Pharma’s Annual General Meeting
Published: 2021-05-28 (Crawled : 22:00) - globenewswire.com
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
| Email alert
Add to watchlist
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
pharma
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
Published: 2021-05-25 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.77%
H: 0.11%
C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: -0.63%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -4.22%
H: 1.04%
C: 0.78%
pharma
Innate Pharma Virtual 2021 Annual General Meeting
Published: 2021-05-12 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.73%
H: 1.3%
C: 1.11%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -3.41%
H: 6.59%
C: 2.78%
pharma
Innate Pharma First Quarter 2021 Report
Published: 2021-05-11 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.89%
H: 1.63%
C: 1.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 4.66%
H: 1.49%
C: 1.49%
report pharma
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
Published: 2021-05-04 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.58%
H: 0.43%
C: -0.03%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.33%
H: 0.32%
C: -0.59%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -1.43%
H: 0.37%
C: 0.37%
conference pharma
Innate Pharma Files its 2020 Universal Registration Document (Document d'Enregistrement Universel) and 2020 Annual Report on Form 20-F
Published: 2021-04-28 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.1%
H: 0.82%
C: 0.69%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.86%
H: 0.89%
C: 0.11%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 0.58%
H: 0.38%
C: -0.33%
pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.